These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16944623)

  • 1. Fenofibrate can increase serum creatinine levels in renal insufficiency.
    Paul S; Mohan V
    J Assoc Physicians India; 2006 Apr; 54():337. PubMed ID: 16944623
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenofibrate for hypertriglyceridemia.
    Med Lett Drugs Ther; 1998 Jul; 40(1030):68-9. PubMed ID: 9664930
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis.
    Tahmaz M; Kumbasar B; Ergen K; Ure U; Karatemiz G; Kazancioglu R
    Ren Fail; 2007; 29(7):927-30. PubMed ID: 17994463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate].
    Duda-Król W; Jórasz I; Dabrowska M; Polubiec A; Kusz-Rynkun A
    Wiad Lek; 2000; 53(7-8):454-7. PubMed ID: 11070769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate-associated reversible acute allograft dysfunction in 3 renal transplant recipients: biopsy evidence of tubular toxicity.
    Angeles C; Lane BP; Miller F; Nord EP
    Am J Kidney Dis; 2004 Sep; 44(3):543-50. PubMed ID: 15332227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate-induced myopathy.
    Ghosh B; Sengupta S; Bhattacharjee B; Majumder A; Sarkar SB
    Neurol India; 2004 Jun; 52(2):268-9. PubMed ID: 15269493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate-induced photosensitivity.
    Leenutaphong V; Manuskiatti W
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):775-7. PubMed ID: 8912578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Muscular toxicity due to fenofibrate. Apropos of a case].
    Giraud P; Cassou M; Paul R; Guidet M
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):162. PubMed ID: 7063798
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypothyroidism and muscular toxicity from fenofibrate, report of a case revealed by polymyositis].
    Cherif O; Karma F; Ben Amor G; Kochbati S; Ben Amor B; Rokbani L
    Tunis Med; 1997 Feb; 75(2):87-91. PubMed ID: 9506029
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced high-density lipoprotein cholesterol in patients receiving rosiglitazone and fenofibrate.
    Venero CV; Thompson PD; Fernandez AB
    Am J Med; 2008 Oct; 121(10):e3-4. PubMed ID: 18823843
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of patients with hypertriglyceridemia].
    Rozhkova TA; Kukharchuk VV; Titov VN; Iarovaia EB; Kotova LA; Malyshev PP; Ameliushkina VA
    Ter Arkh; 2009; 81(9):29-33. PubMed ID: 19827649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
    Taskinen MR; Sullivan DR; Ehnholm C; Whiting M; Zannino D; Simes RJ; Keech AC; Barter PJ;
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):950-5. PubMed ID: 19325138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myopathy caused by a combination rosuvastatin and fenofibrate.
    Dedhia V; Munsi SC
    J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fenofibrate, efficacy and tolerance in long-term treatment (author's transl)].
    Fromantin M; Gautier D; Quatre JM; Bon R
    Therapie; 1981; 36(4):473-6. PubMed ID: 7292431
    [No Abstract]   [Full Text] [Related]  

  • 15. Paradoxical decreases in high-density lipoprotein cholesterol with fenofibrate: a quite common phenomenon.
    Magee G; Sharpe PC
    J Clin Pathol; 2009 Mar; 62(3):250-3. PubMed ID: 19251953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecomastia associated with fenofibrate.
    Gardette V; Vezzosi D; Maiza JC; Montastruc JL; Olivier P
    Ann Pharmacother; 2007 Mar; 41(3):508-10. PubMed ID: 17341535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.
    Rosenson RS; Wolff DA; Huskin AL; Helenowski IB; Rademaker AW
    Diabetes Care; 2007 Aug; 30(8):1945-51. PubMed ID: 17483155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Tricor cause gallstones?
    Lee T
    Harv Heart Lett; 2008 Jul; 18(11):8. PubMed ID: 18697244
    [No Abstract]   [Full Text] [Related]  

  • 19. [Elevated serum creatinine. Diagnosis orientation].
    Canaud B
    Rev Prat; 2008 Oct; 58(16):1837-46. PubMed ID: 19143158
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible mechanisms of the fibrate-induced increase in serum creatinine.
    Tsimihodimos V; Miltiadous G; Bairaktari E; Elisaf M
    Clin Nephrol; 2002 May; 57(5):407-8. PubMed ID: 12036205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.